Pharmaceutical News

RSS

AMDL Diagnostics to focus on in vitro diagnostic cancer tests

AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced the inauguration of AMDL Diagnostics Inc. (ADI), a new wholly-owned subsidiary that will focus on the research, development, manufacture and international sales of Onko-Sure(TM)-- AMDL's proprietary, regulatory approved in vitro diagnostic (IVD) cancer test.

21 Aug 2009

Federal guidelines for seasonal and swine flu vaccines questioned

With the seasonal flu season approaching and uncertainty over whether swine flu will become more severe, new research published by Yale School of Public Health has found that more people are likely to avoid illness if vaccines are given out first to those most likely to transmit viruses, rather than to those at highest risk for complications.

20 Aug 2009

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study

Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on bmj.com today.

20 Aug 2009

Consumer groups urge transparency in health care reform for pharmacy benefit managers

Three top consumer groups are urging Congress to include in health care reform legislation transparency requirements for pharmacy benefit managers (PBMs) participating in any new federally sponsored health plans in a public health care exchange. The Consumer Federation of America (CFA), U.S. Public Interest Research Group (PIRG), and the National Legislative Association on Prescription Drug Prices (NLARx) have sent a joint letter to House Speaker Nancy Pelosi (D-CA) supporting the provision, authored by Rep. Anthony Weiner (D-NY) and included in the House Energy and Commerce Committee’s America’s Affordable Health Choices Act of 2009 (H.R. 3200).

20 Aug 2009

Cambodia's maternal mortality; drugs in Uganda; cholera risk in Zimbabwe; HIV laws in Niger

A lack of outreach by public health officials and rural villagers' preference for traditional midwives have hindered efforts to reduce maternal morality in Cambodia, government officials said recently at regional conference, the Phnom Penh Post reports.

20 Aug 2009

Chemical components of elderberry, cinnamon and green tea extracts block HIV viruses from infecting cells

The development of new antiviral drugs has had a tremendous impact on the quality of life and life expectancy of HIV-positive and AIDS patients, as the drugs effectively disrupt the replication cycle of the HIV virus. Yet the regular use of those drugs - such as zidovudine (also known as azidothymidine or AZT), protease inhibitors, and highly active antiretroviral therapy (HAART) involving multidrug therapies - has led to resistant HIV strains.

20 Aug 2009

Advaxis awarded $210,000 for development of a dual antigen vaccine

Advaxis, Incorporated (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, has been awarded a $210,000 grant from the US National Institute of Health (NIH) to develop a single bioengineered Lm vaccine to deliver two different antigen-adjuvant proteins.

20 Aug 2009

Seasonal flu vaccinations to cost less in Safeway's U.S. Stores

Safeway Inc. (NYSE:SWY) added to its leadership reputation in health care reform and cost control by offering seasonal flu vaccines in its U.S. stores at a substantial savings compared with the cost of doctor-administered vaccines. The lower cost will help consumers and businesses control health care spending in a challenging economy.

20 Aug 2009

RBC Life Sciences reports on patent-pending, nutritional supplement

RBC Life Sciences, Inc., a provider of proprietary nutritional supplements and wound care/pain management products, announced today the debut of NeuroBright(TM), a patent-pending, nutritional supplement that improved test subjects' learning and memory skills by 50 percent during a recent laboratory trial.

20 Aug 2009

Wraser purchases Trezix oral capsule product from e5 Pharma

WraSer Pharmaceuticals, LLC (WraSer) announced that it has purchased the Trezix® Oral Capsule product from e5 Pharma, LLC. With the purchase, WraSer is granted full rights to market and distribute Trezix® in the United States.

20 Aug 2009

Aton Pharma markets preservative-free drugs for glaucoma

Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.

20 Aug 2009

Imagenetix announces retail distribution of InflameAway Celadrin(R) gels for promoting joint health

Imagenetix, Inc. (OTC Bulletin Board: IAGX) announced that InflameAway Celadrin(R) extra strength soft gels for joint health are currently available at the nation's number one drug chain, the number one and number two supermarket stores and the number one club warehouse store. This retail distribution provides a platform for future retail gains as well as additional product launches, including a 100 count value size.

20 Aug 2009

Phrma brushes off Republican leader's attacks

"The prescription drug industry's lobbying arm is defending its deal with President Barack Obama in the wake of criticism from House Minority Leader John Boehner, who charged it with 'appeasing' the Obama administration," The Hill reports.

19 Aug 2009

FDA approves Hiberix Haemophilus influenzae type b vaccine

In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE: GSK) has received accelerated approval from the FDA (Food and Drug Administration) for Hiberix((R)) [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] as a booster dose in children 15 months through four years of age. Hib is an often severe and potentially deadly bacterial infection that can cause meningitis.

19 Aug 2009

Mylan files lawsuit against Pittsburgh Post-Gazette, Post-Gazette reporters

Mylan Inc. (Nasdaq: MYL) today announced that the company and its subsidiary Mylan Pharmaceuticals Inc. filed a civil lawsuit in the Circuit Court of Monongalia County, W.Va., against the Pittsburgh Post-Gazette, Post-Gazette reporters Len Boselovic and Patricia Sabatini, and others as yet unknown.

19 Aug 2009

The Gambia introduces pneumococcal immunisation programme

The Gambia, Minister of Health Dr. Mariatou Jallow administered the first dose of the pneumococcal vaccine to Gambian children at a rural clinic outside Banjul today. Joined by the Gambia’s Vice President, Mrs. Isatou Njie-Saidy, Dr. Jallow and hundreds of Gambian citizens celebrated this historic event, which marks the first step in the rollout of the Gambia’s national pneumococcal immunisation programme.

19 Aug 2009

AstraZeneca Canada files a New Drug Submission (NDS) for FluMist in Canada

AstraZeneca Canada Inc. announced today that it has filed a New Drug Submission (NDS) for FluMist(R) (Influenza Vaccine, Live Attenuated Intranasal) with Health Canada.

19 Aug 2009

H1N1 vaccine orders top 1 billion, WHO Says

"Northern hemisphere countries have so far ordered more than one billion doses of swine flu vaccine, the World Health Organisation said Tuesday, sparking warnings over shortages," Agence France-Presse reports. While some countries, including Greece, The Netherlands, Canada and Israel, have ordered enough vaccine to inoculate their citizens, "[o]thers, such as Germany, the United States, Britain and France, have put in orders that would cover between 30 and 78 percent of people," the news service writes.

19 Aug 2009

U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals

Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad((R)) mucoadhesive buccal tablets (MBT) to treat oropharyngeal candidiasis (OPC).

19 Aug 2009

Omnia Biologics and Aparna Biosciences sign agreement on lentivirus drug development

Biologics contract manufacturer Omnia Biologics, Inc. (Omnia) (Rockville, MD) and drug development company Aparna Biosciences Corp. (AparnaBio) (Rockville, MD) today announced a deal for Omnia to provide AparnaBio with process development and production services. Omnia will provide lentiviral vector technical services as well as manufacture of research grade through cGMP grade materials.

19 Aug 2009

Pharmaceutical News

AMDL Diagnostics to focus on in vitro diagnostic cancer tests

Federal guidelines for seasonal and swine flu vaccines questioned

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study

Consumer groups urge transparency in health care reform for pharmacy benefit managers

Cambodia's maternal mortality; drugs in Uganda; cholera risk in Zimbabwe; HIV laws in Niger

Chemical components of elderberry, cinnamon and green tea extracts block HIV viruses from infecting cells

Advaxis awarded $210,000 for development of a dual antigen vaccine

Seasonal flu vaccinations to cost less in Safeway's U.S. Stores

RBC Life Sciences reports on patent-pending, nutritional supplement

Wraser purchases Trezix oral capsule product from e5 Pharma

Aton Pharma markets preservative-free drugs for glaucoma

Imagenetix announces retail distribution of InflameAway Celadrin(R) gels for promoting joint health

Phrma brushes off Republican leader's attacks

FDA approves Hiberix Haemophilus influenzae type b vaccine

Mylan files lawsuit against Pittsburgh Post-Gazette, Post-Gazette reporters

The Gambia introduces pneumococcal immunisation programme

AstraZeneca Canada files a New Drug Submission (NDS) for FluMist in Canada

H1N1 vaccine orders top 1 billion, WHO Says

U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals

Omnia Biologics and Aparna Biosciences sign agreement on lentivirus drug development

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News